Login / Signup
Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits.
Huai-Liang Wu
Zi-Yin Luo
Zong-Lin He
Yue Gong
Miao Mo
Wai-Kit Ming
Guang-Yu Liu
Published in:
British journal of cancer (2023)
Keyphrases
</>